Vincenzo Di Marzo Maurizio Bifulco& Luciano De Petrocellis The endocannabinoid system and its therapeutic exploitation, Nature Reviews Drug Discovery, 771-784 (September 2004) | doi:10.1038/nrd1495
Silvia Conti, Barbara Costa, Mariapia Colleoni, Daniela Parolaro, Gabriella Giagnoni Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat, British Journal of Pharmacology, January 2002
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202504Natalya M. Kogan, MSc, Raphael Mechoulam, Ph.D, Cannabinoids in Health and Disease, Diaglogues Clin Neurosci, 2007 Dec; 9(4): 413–430.
Fiona A Campbell, Martin R Tramèr, Dawn Carroll, D John M Reynolds, R Andrew Moore, Henry J McQuay. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ2001; 323doi: https://doi.org/10.1136/bmj.323.7303.13(Published 07 July 2001) Cite this as: BMJ 2001; 323:13
Mary E. Lynch, Fiona CampbellCannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials British Journal of Clinical Pharmacology, 11 October 2011, DOI: 10.1111/j.1365-2125.2011.03970.x http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2011.03970.x/full
University of Bonn. “Cannabis reverses aging processes in the brain, study suggests: Researchers restore the memory performance of Methuselah mice to a juvenile stage.” ScienceDaily. ScienceDaily, 8 May 2017. <www.sciencedaily.com/releases/2017/05/170508112400.htm>
Di Marzo, The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008 Aug;51(8):1356-67. doi: 10.1007/s00125-008-1048-2. Epub 2008 Jun 18. https://link.springer.com/article/10.1007/s00125-008-1048-2
Aviello G, Romano B, Izzo AA, Cannabinoids and gastrointestinal motility: animal and human studies. Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:81-93. https://www.ncbi.nlm.nih.gov/pubmed/18924447
Sabine Steffens, Niels R. Veillard, Claire Arnaud, Graziano Pelli, Fabienne Burger, Christian Staub, Andreas Zimmer, Jean-Louis Frossard & François Mach, Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice; Nature 434, 782-786 (7 April 2005) | doi:10.1038/nature03389; Received 26 October 2004; Accepted 21 January 2005.https://www.nature.com/nature/journal/v434/n7034/full/nature03389.html
Béla Horváth, Partha Mukhopadhyay,György Haskó, Pál Pacher; The Endocannabinoid System and Plant-DerivedCannabinoids in Diabetes and Diabetic Complications. The American Journal of Pathology. . 2012 Feb; 180(2): 432–442. doi: 10.1016/j.ajpath.2011.11.003 PMCID: PMC3349875. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
Nora D. Volkow, Director, The Biology and Potential Therapeutic Effects of Cannabidiol; National Institute on Drug Abuse. Senate Caucus on International Narcotics Control; June 24, 2015
El-Alfy, Abir T, et al, “Indirect modulation of the endocannabinoid system by specific fractions of nutmeg total extract,” Pharmaceutical Biology, 2016.
Nora D. Volkow, Director, National Institute on Drug AbuseSenate Caucus on International Narcotics ControlTestimony to Congress, The Biology and Potential Therapeutic Effects of Cannabidiol; June 24, 2015
Nandini Acharya, Sasi Peukonda, Tatiana Shcheglove, Adam Hagymasi, Sreyashi Basu, Pramod Srivastava. Endocannabinoid system acts as a regulator of immune homeostasis in the gut, Proceedings of the Natioanl Academy of Sciences of the United States of America. March 27, 2017, vol. 114 no. 19 5005–5010, doi: 10.1073/pnas.1612177114
García C, Palomo-Garo C, García-Arencibia M, Ramos J, Pertwee R, Fernández-Ruiz J. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease. British Journal of Pharmacology. 2011;163(7):1495-1506. doi:10.1111/j.1476-5381.2011.01278.x.
Martín-Moreno AM, Reigada D, Ramírez BG, et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease. Molecular Pharmacology. 2011;79(6):964-973. doi:10.1124/mol.111.071290.
Das RK, Kamboj SK, Ramadas M, Yogan K, Gupta V, Redman E, Curran HV, Morgan CJ. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology (Berl). 2013 Apr;226(4):781-92. doi: 10.1007/s00213-012-2955-y. Epub 2013 Jan 10
Neelakantan H, Tallarida RJ, Reichenbach ZW, Tuma RF, Ward SJ, Walker EA. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behav Pharmacol. 2015 Apr;26(3):304-14
Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, Guan Y, Pan HL, Ren K, Xu Y, Zhang L.Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J Exp Med. 2012 Jun 4;209(6):1121-34. doi: 10.1084/jem.20120242. Epub 2012 May 14.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011 May;36(6):1219-26.
Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014;5(15):5852-5872.
